Please assess the completion status of the following clinical trial:

Trial Title: The Impact of Vitamin D on Disease Activity in Crohn's Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* newly diagnosis with an active Crohn's disease,~* age above of 16 years~Exclusion Criteria:~* remission or the duration of disease is more than 2 years,~* pregnancy,~* liver or kidney failure,~* inability to take oral supplements or medicine

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Group 3 (Type: EXPERIMENTAL): Vitamin D3, 10,000 IU daily
- Group 2 (Type: EXPERIMENTAL): Vitamin D3 2,000 IU daily
- Group 1 (Type: EXPERIMENTAL): Vitamin D3 600 IU daily (Control group, RDA level)

Based on this trial design, predict the completion outcome and termination type (if applicable).